CTRI/2023/10/058761尚未招募Unknown
Clinical outcomes of Ceftazidime-Avibactam Versus Polymyxins in Critically ill Patients With Carbapenem Resistant Enterobacteraceae Infections in Tertiary Care Hospital
Research institution0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1.Critically ill patients admitted in ICU with features of Sepsis
- •2.Microbiological culture confirmed CRE infection (Pulmonary and Blood stream)
- •3.Patients who have received CAZ/AVI or Polymyxins for at least 72 hours
排除标准
- •1.Polymicrobial cultures
- •2.Patients who have already received CAZ/AVI or Polymyxins before ICU admission
- •3.Patients with CKD
- •4.Patients with chemotherapy or immunosuppressant therapy in last three months
- •Post organ transplant patients
研究者
相似试验
尚未招募
1 期
Comparing the efficacy of two antibiotic groups for gram negative sepsis in intensive care unitCTRI/2024/04/065863Trishita Saha
尚未招募
Unknown
rosepsis and Intra abdominal SepsisCTRI/2024/05/066803Pfizer PHARMACEUTICALS
进行中（未招募）
Unknown
Effectiveness of newer antibiotic combination named as ceftazidime avibactam for the treatment of blood infection due to Multi Drug Resistant gram negative bacteria.CTRI/2023/06/054356Medanta Institute of Education and Research
尚未招募
4 期
Impact of Rapid Diagnostics using a FilmArray Test and Early Targeted Treatment with Ceftazidime-Avibactam for Management of Severe Infections: A Comparative Study Against Standard CareCTRI/2024/04/066197ADVANCE ID
尚未招募
4 期
Comparison of two combination of antibiotics for Extensively drug resistant Gram Negative Bacteria in ICU patientsCTRI/2020/03/024343FMRI